Critical illness associated hyperglycemia
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: * Informed consent. * Age > 18 years. * Admitted to the ICU of the Academic Medical Center. * Expected ICU stay of * 3 days at the time of enrolment (as judged by Principle Investigator). * APACHE II score of * 10. * Existing central venous catheter + arterial catheter. * No participating in any other investigational interventional study while enrolled in this study.
Exclusion criteria
Exclusion criteria: * Have received any investigational product or been treated with an investigational device within the past 30 days. * Pregnancy. * Untreatable colonization with multi*resistant bacteria (e.g., methicillin*resistant Staphylococcus aureus).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| * Glucose prediction error, defined as [the YSI (the "gold standard") versus the OptiScanner result, as well as all other measurement technologies used on central venous blood]. * Clarke Error Grid analysis between the YSI and the OptiScanner result, to show the percentage of paired data values falling within each zone. * Linearity between the YSI and the OptiScanner, as well as all other measurement technologies used on central venous blood. | — |
Secondary
| Measure | Time frame |
|---|---|
| * Glucose prediction error, defined as [the YSI versus all other measurement technologies used on arterial blood]. * Clarke error grid analysis between the YSI and all other measurement technologies used on arterial blood. * Linearity between the YSI and all other measurement technologies used on arterial blood. | — |
Countries
Netherlands